GlaxoSmithKline Pharmaceuticals Ltd. reported a 22 percent drop in profit in the quarter ended June, while revenue came in line with analyst estimates.
Profit fell to Rs 72.27 crore from Rs 94 crore in the same quarter last year, the Indian subsidiary of GlaxoSmithKline Plc., said in its filing to the exchanges. This was worse than the Rs 108 crore consensus of analyst estimates compiled by Bloomberg.
ADVERTISEMENT
Revenue grew 8 percent to Rs 685 crore, compared to the Bloomberg consensus estimate of Rs 699 crore.
The margin on earnings before interest, taxes, depreciation and amortisation contracted 430 basis points to 13.2 percent versus 17.5 percent in the same quarter last year.
WRITTEN BY
RECOMMENDED FOR YOU
POPULAR
1
SEPC To Raise Authorised Share Capital To Rs 2,250 Crore From Rs 1,750 Crore
2
Nepal To Export 40 MW Of Electricity To Bangladesh Via India For One Day On Friday
3
Jharkhand Assembly Elections: 127 Crorepati Candidates To Contest, 28% Have Criminal Cases
4
KPI Green Energy Board Recommends 1:2 Bonus Share Issue
5